ClinicalTrials.gg
CompletedNCT07669870Updated Jun 25, 2026

LOW LEVEL LASER THERAPY VS EXERCISES FOR SNORING IN SLEEP APNEA 'S PATIENTS

An interventional study of low level laser therapy and oropharyngeal exercises in Obstructive Sleep Apnea and Snoring, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 40 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2026, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
40 Years to 55 Years
Sex
All
01

Study summary

the purpose of this study is to evaluate and compare the effectiveness of using low level laser therapy versus oropharyngeal exercises in the treatment of snoring in patient diagnosed with obstructive sleep apnea.

the study aims to determine which intervention provide better clinical outcome in reducing snoring severity and improve sleep quality

Read the detailed description

patients participating in this study were randomly allocated into parallel group to evaluate the therapeutic effects on snoring . one group received low level laser therapy targeting soft palate while second group received oropharyngeal and tongue exercises to strengthen upper air way muscles the treatment outcome were evaluated before and after the intervention period . the primary clinical assessment for snoring risk and severity was conducted using berlin questionnaire .

statistical analysis was performed to compare the pre and post treatment result between the groups to identify the most effective non invasive treatment modality for snoring in sleep apnea patients

02

Conditions studied

  • Obstructive Sleep Apnea
  • Snoring
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's enrollment of 180 is above the median of 52 across 1,472 interventional studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion criteria :

    1. Patient are clinically and medically stable 2-Patients are able to understand and follow the instruction 3-Patient 's age range from 40 to 55 years old 4-Patient are male and females 5-Patient have snoring due to diagnostic mild sleep apnea disorder 6- of patients ranging from (30 - 34.9) Obesity Class I and obesity class 2 ( 35-39)

      Exculsioncriteria :

    <!-- -->

    1. In stability of patient 's medical condition 3-In ability to comprehered and follow instruction as in dementia or speech proplems such as dysphasia 4-Patients with cognitive disorders 5-Patients with musculoskeletal and neurological problems 6- patients with diabetes
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (actual)

Study arms

  • Experimental
    laser therapy group

    patients in this group received low level laser therapy targeting soft palate and surrounding upper airway tissues

    Device: low level laser therapy

  • Experimental
    orophrgeal exercises

    patient in this group performed oropharyngeal exercises and tongue exercises to strengthen upper air way

    Behavioral: oropharyngeal exercises

  • No intervention
    control group

    patient in this group didn't receive any active exercises or laser they receive only advices

Interventions

  • Devicelow level laser therapy

    laser applications to the oral mucosa and soft palate tissue

  • Behavioraloropharyngeal exercises

    structured myofunctional and tongue strengthening exercises for snoring reduction

06

What researchers measure

Primary outcomes

  1. snoring severity and risk using the berlin questionnaire

    the Berline questionnaire is used to assess the risk and severity and obstructive sleep apnea .it consist of 3 categories addressing the severity of snoring, day time sleepiness, and history of high blood pressure or obesity changes in the questionnaire scores will be evaluated to compare the clinical outcome between the groups

    Time frame: 6 weeks

07

Study locations

1 site
  • Faculty of Physcial Therapy Cairo Unvirsity
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No — to maintain participant confidentiality and comply with the regulation of the institutional research ethical committee

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07669870
Lead sponsor
Cairo University
Responsible party
mina gorgy aziz gorgy (physiotherapist, Cairo University) — Principal investigator
First posted
Jun 25, 2026
Start date
Jan 1, 2026
Primary completion
May 1, 2026
Completion
Jun 5, 2026
Last update
Jun 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion